Completed PHASE2 INTERVENTIONAL 4-arm NCT04041453

Albendazole Plus High Dose Ivermectin for Trichuriasis in Pediatric Patients (HI4T)

Prospective, Parallel-group, Open-label Randomized Controlled Trial of Four Treatment Regimes for Trichuriasis in Pediatric Patients

Sponsor: Alejandro Krolewiecki

Conditions Helminthiasis Trichuris Infection

Interventions Albendazole Ivermectin

Updated 8 times since 2019 Last updated: Jul 27, 2020 Started: Oct 9, 2019 Primary completion: Mar 7, 2020 Completion: Mar 7, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Helminthiasis and Trichuris Infection and is currently completed. Alejandro Krolewiecki leads this study, which shows 8 recorded versions since 2019 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2023 — Jul 2024 [monthly]

Completed PHASE2
Dec 2022 — Jan 2023 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Jan 2021 — Dec 2022 [monthly]

Completed PHASE2
Aug 2020 — Jan 2021 [monthly]

Completed PHASE2

Status: Not Yet Recruiting → Completed
Sep 2019 — Aug 2020 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alejandro Krolewiecki
Brock University
Universidad Nacional Autonoma de Honduras
Universidad Nacional del Centro de la Provincia de Buenos Aires

Data source: Universidad Nacional de Salta

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Orán, Argentina
• Tegucigalpa, Honduras